Metacrine, Inc. (MTCR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO, CA 92121

Metacrine, Inc. is a clinical-stage biopharmaceutical company building a pipeline of differentiated therapies to treat liver and gastrointestinal diseases. Metacrine has developed a proprietary farnesoid X receptor (FXR) platform utilizing a unique chemical scaffold, which has demonstrated an improved therapeutic profile in clinical trials. The Company’s two product candidates, MET409 and MET642, are currently being investigated in clinical trials as potential new treatments for NASH. MET409 has completed a 12-week monotherapy trial in patients with NASH and is being evaluated in a 12-week combination trial with empagliflozin in patients with both NASH and type 2 diabetes. MET642 has completed a 14-day Phase 1 trial in healthy volunteers and is being evaluated in a 16-week monotherapy trial in patients with NASH.

Data as of 2021-07-19 10:06:00 -0400
Market Cap84.29 Million Shares Outstanding26.423 Million Avg 30-day Volume201.33 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE31.9 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low16.19 / 3.06 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MTCR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 48 43 11.63% 15 (0.88%) 14 (0.81%) 7.14%
13F shares: 13.239 Million 13.309 Million -0.53% 3.217 Million 3.712 Million -13.35%
% Ownership 50.9473 51.2749 -0.64% 12.3781 14.3012 -13.45%
New Positions: 6 23 -73.91% 1 5 -80.0%
Increased Positions 12 7 71.43% 3 3 0.0%
Closed Positions 1 6 -83.33% 3
Reduced Positions 15 6 150.0% 7 4 75.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MTCR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MTCR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCHUTCHISON JOHN G

  • Director
16,500 2021-05-24 2

EVANS RONALD M

  • Director
16,500 2021-05-24 3

BUROW KRISTINA

  • Director
16,500 2021-05-24 3

GUGGENHIME ANDREW

  • Director
16,500 2021-05-24 2

NASHAT AMIR

  • Director
  • 10% Owner
16,500 2021-05-24 3

HEYMAN RICHARD A.

  • Director
16,500 2021-05-24 2

JONKER JEFFREY DAVID

  • Director
16,500 2021-05-24 3

OWENS JULIA C.

  • Director
16,500 2021-05-24 3

KLASSEN PRESTON PRESIDENT & CEO

  • Officer
  • Director
20,547 2021-05-20 3

CHEN HUBERT C CHIEF MEDICAL OFFICER

  • Officer
3,289 2021-05-20 3

MILLICAN TRISHA CHIEF FINANCIAL OFFICER

  • Officer
109,040 2021-05-05 4

LEE CATHERINE CHAI-ZON EVP, GEN. COUNSEL & SECRETARY

  • Officer
3,846 2021-05-05 3

ARCH VENTURE FUND VIII, L.P.

ARCH VENTURE FUND VIII OVERAGE, L.P.

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

ARCH VENTURE PARTNERS VIII, LLC

ARCH VENTURE PARTNERS VIII, L.P.

  • 10% Owner
2,940,503 2020-09-18 2

POLARIS MANAGEMENT CO. VII, L.L.C.

POLARIS ENTREPRENEURS' FUND VII, L.P.

POLARIS PARTNERS VII, L.P.

  • 10% Owner
2,894,258 2020-09-18 2

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
3,060,527 2020-09-18 2

WALKER PAUL EDWARD

  • 10% Owner
3,060,527 2020-09-18 2

SONSINI PETER W.

  • 10% Owner
3,060,527 2020-09-18 2

SANDELL SCOTT D

  • 10% Owner
3,060,527 2020-09-18 2

MAKOWER JOSHUA

  • 10% Owner
3,060,527 2020-09-18 2

MAKHZOUMI MOHAMAD

  • 10% Owner
3,060,527 2020-09-18 2

FLORENCE ANTHONY A. JR.

  • 10% Owner
3,060,527 2020-09-18 2

BEHBAHANI ALI

  • 10% Owner
3,060,527 2020-09-18 2

BASKETT FOREST

  • 10% Owner
3,060,527 2020-09-18 2

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
No longer subject to file 2020-09-18 2

CHANG CARMEN

  • 10% Owner
3,060,527 2020-09-18 2

ADELMAN ROBERT J

3,059,123 2020-09-18 2

VENBIO GLOBAL STRATEGIC FUND, L.P.

VENBIO GLOBAL STRATEGIC GP, L.P.

VENBIO GLOBAL STRATEGIC GP, LTD.

GOODMAN COREY S

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
3,059,123 2020-09-18 2

GALLAGHER CAROL GILTNER

  • Director
0 2020-09-15 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
METACRINE INC MTCR 2021-07-23 22:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 21:45:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 21:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 20:45:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 20:15:05 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 19:45:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 19:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 18:45:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 18:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 17:45:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 17:15:02 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 16:45:02 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 16:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 15:45:02 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 15:15:03 UTC -0.55 0.63 250000
METACRINE INC MTCR 2021-07-23 14:45:03 UTC -0.6068 0.6868 250000
METACRINE INC MTCR 2021-07-23 14:15:03 UTC -0.6068 0.6868 250000
METACRINE INC MTCR 2021-07-23 13:45:03 UTC -0.6068 0.6868 250000
METACRINE INC MTCR 2021-07-23 13:15:03 UTC -0.6068 0.6868 250000
METACRINE INC MTCR 2021-07-23 12:45:03 UTC -0.6068 0.6868 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments